[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594861":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":24,"locations":33,"responsibleParty":47,"collaborators":51,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":12,"enrollmentInfo":69,"targetDuration":12,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":79,"overallStatus":88,"whyStopped":12,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Dartmouth-Hitchcock Medical Center","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm 1 is Usual Care","NO_INTERVENTION","The clinicians in the nephrology clinic will proceed with usual care without intervention from the study team.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Arm 2 is Clinical Visit Agenda Setting Tool Intervention","EXPERIMENTAL","The study team will implement a structured clinical visit agenda-setting (SAS) intervention customized for advanced chronic kidney disease, called Chronic Kidney Disease (CKD) Topics.",[18],"Other: Chronic Kidney Disease Structured Agenda-Setting Tool",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"Chronic Kidney Disease Structured Agenda-Setting Tool","Chronic Kidney Disease (CKD) Topics is a novel clinical visit agenda-setting intervention developed through participatory research methods for people with CKD living in rural areas. CKD Topics includes structured discussion topic areas.",[14],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":12,"email":29},"Catherine H. Saunders, Assistant Professor of Medicine and of Health Policy, PhD, MPH","CONTACT","603-653-3436","Catherine.Hylas.Saunders@dartmouth.edu",{"name":31,"role":27,"phone":12,"phoneExt":12,"email":32},"Anne E. Dade, Research Associate, MPP","Anne.E.Dade@dartmouth.edu",[34],{"facility":35,"status":12,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":12},"Dartmouth Hitchcock Medical Center","Lebanon","New Hampshire","03766","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-72.25176,43.64229,{"lat":45,"lon":44},{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Catherine Hylas Saunders","Scientist & Assistant Professor of Medicine and of Health Policy & Clinical Practice",[52,54,56],{"name":53,"class":6},"Dartmouth College",{"name":55,"class":6},"University of Washington",{"name":57,"class":58},"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","NIH","100594861","the-agenda-setting-for-kidney-disease-trial-100594861",false,"NCT07024953","The Agenda-Setting for Kidney Disease Trial","Setting the Agenda: A Pilot Stepped Wedge Cluster Randomized Trial of a Structured Clinical Visit Agenda-Setting Intervention for Rural-Residing People With Advanced Chronic Kidney Disease","ASK","Inclusion Criteria:\n\n* Adults \\>18 years old who have been diagnosed with advanced CKD (stages 4-5).\n* Care partners, clinicians and staff supporting these CKD patients who are willing and able to provide informed consent\n* English-speaking\n* Able to provide informed consent\n* Patient must be attending outpatient visits \\*(in-person and\u002For telehealth allowable).\n\nExclusion Criteria:\n\n* Children under 18 years old will not be included\n* Non-English-speaking patients and\u002For care partners\n* Patients on dialysis\n* Individuals unable or unwilling to provide informed consent","ALL","18 Years",{"count":70,"type":71},108,"ESTIMATED","INTERVENTIONAL",[74],"NA","The goal of this clinical trial is to learn if a tool with a list of discussion topics, called a structured clinical visit agenda-setting intervention (SAS), works for people with advanced chronic kidney disease (CKD) who receive care at a clinic that serves people who live in rural areas. The SAS is called CKD Topics. The researchers will compare the SAS intervention to usual care (the way clinicians usually practice) to see how well it works for people with advanced CKD. This is a special type of clinical trial called a stepped wedge randomized clinical trial (RCT). In this type of trial, every participant will get to experience both usual care and CKD Topics, but for different amounts of time.\n\nThe researchers will learn if doing a clinical trial of CKD Topics is possible (feasible) and get information about how well CKD Topics helps people with advanced CKD shape visit discussions (self-advocacy) in their appointments with their clinicians. The information the researchers collect in this trial will help design a future trial with more participants.\n\nThe main questions the researchers aim to answer are:\n\n* Is it possible to conduct this type of study of a SAS intervention? i.e. feasibility\n* Does the SAS intervention help people with advanced CKD shape discussions (self-advocacy) with their clinicians? If so, how much? i.e. preliminary efficacy",[77,78],"Chronic Kidney Disease Stage 4","Chronic Kidney Disease Stage 5",[80,81,82,83,84,85,86,87],"Chronic Kidney Disease","Chronic kidney disease stage 4","Chronic kidney disease stage 5","Agenda-setting","Rural","Patient engagement","Randomized trial","Participatory research","NOT_YET_RECRUITING","2025-06-18",{"date":91,"type":92},"2025-06-24","ACTUAL",{"date":94,"type":71},"2026-09-01",{"date":96,"type":71},"2028-12",{"name":5,"class":6},1]